Prospects for the Future in the Management of Carcinoma of the Breast: the Biological Fall out from Clinical Trials

Overview

Journal Br J Cancer

Specialty Oncology

Date 1984 Feb 1

PMID 6696816

Citations 3

Authors

M Baum

Affiliations

Soon will be listed here.

Citing Articles

Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer.

Wilson A, Baum M, BRINKLEY D, DOSSETT J, McPherson K, Patterson J World J Surg. 1985; 9(5):756-64.

PMID: 3904233 DOI: 10.1007/BF01655191.

Skeletal effects of carcinoma of the breast and prostate.

Percival R Ann R Coll Surg Engl. 1986; 68(5):267-70.

PMID: 3789624 PMC: 2498336.

Progress in understanding breast cancer: epidemiological and biological interactions.

Boyle P, Leake R Breast Cancer Res Treat. 1988; 11(2):91-112.

PMID: 3042054 DOI: 10.1007/BF01805834.

References

Baum M, Fisher B . Macrophage production by the bone marrow of tumor-bearing mice. Cancer Res. 1972; 32(12):2813-7. View

Peto R, Pike M, Armitage P, Breslow N, Cox D, Howard S . Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976; 34(6):585-612. PMC: 2025229. DOI: 10.1038/bjc.1976.220. View

Rose D, Davis T . Ovarian function in patients receiving adjuvant chemotherapy for breast cancer. Lancet. 1977; 1(8023):1174-6. DOI: 10.1016/s0140-6736(77)92716-7. View

Meyer J, Rao B, Stevens S, White W . Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication. Cancer. 1977; 40(5):2290-8. DOI: 10.1002/1097-0142(197711)40:5<2290::aid-cncr2820400541>3.0.co;2-t. View

Freiman J, CHALMERS T, SMITH Jr H, Kuebler R . The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med. 1978; 299(13):690-4. DOI: 10.1056/NEJM197809282991304. View

Priestman T, Baum M, Jones V, Forbes J . Treatment and survival on advanced breast cancer. Br Med J. 1978; 2(6153):1673-4. PMC: 1608971. DOI: 10.1136/bmj.2.6153.1673. View

Devitt J . THE SIGNIFICANCE OF REGIONAL LUMPH NODE METASTASES IN BREAST CARCINOMA. Can Med Assoc J. 1965; 93:289-93. PMC: 1928710. View

Fisher B, Redmond C, Fisher E . The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology--an overview of findings. Cancer. 1980; 46(4 Suppl):1009-25. DOI: 10.1002/1097-0142(19800815)46:4+<1009::aid-cncr2820461326>3.0.co;2-h. View

Bonadonna G, Valagussa P . Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med. 1981; 304(1):10-5. DOI: 10.1056/NEJM198101013040103. View

10.

Coughlin S, Moskowitz M, Zetter B, Antoniades H, Levine L . Platelet-dependent stimulation of prostacyclin synthesis by platelet-derived growth factor. Nature. 1980; 288(5791):600-2. DOI: 10.1038/288600a0. View

11.

Kon O . An antiestrogen-binding protein in human tissues. J Biol Chem. 1983; 258(5):3173-7. View

12.

Bennett A, Berstock D, Carroll M, Stamford I, Wilson A . Breast cancer, its recurrence, and patient survival in relation to tumor prostaglandins. Adv Prostaglandin Thromboxane Leukot Res. 1983; 12:299-302. View

13.

Baum M, BRINKLEY D, DOSSETT J, McPherson K, Patterson J, Rubens R . Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer. Lancet. 1983; 2(8347):450. DOI: 10.1016/s0140-6736(83)90406-3. View

14.

Cooper R, HOLLAND J, GLIDEWELL O . Adjuvant chemotherapy of breast cancer. Cancer. 1979; 44(3):793-8. DOI: 10.1002/1097-0142(197909)44:3<793::aid-cncr2820440302>3.0.co;2-y. View